INS and intestinal neoplasm: According to previous studies, insulin promotes colon cancer progression by increasing the expression of acyl-coenzyme A: cholesterol acyltransferase-1 [30], and vascular cell adhesion molecule-1 in intestinal tumor endothelial cells, resulting in an inflammatory response that promotes malignancy [31].